Drug‐Coated Balloons Versus Drug‐Eluting Stents for Patients With Long De Novo Coronary Artery Lesions: Insights From the REC‐CAGEFREE I Trial
Catheterization and Cardiovascular Interventions · 2026-08 · 108 (2) · 473-482
DOI: 10.1002/ccd.70679 ↗At a glance
Vergleichsstudie in Catheterization and Cardiovascular Interventions, published online on 2026-05-27. Written by Yuehao Lv and 28 co-authors. Institution: Department of Cardiology, Xijing Hospital, The Fourth Military Medical University, Xi'an, China. Major MEDLINE topics: Drug-Eluting Stents, Angioplasty, Balloon, Coronary, Coronary Artery Disease, Coated Materials, Biocompatible. 37 references. The full text is freely available in PubMed Central. Funded by: Xijing Hospital, Noncommunicable Chronic Diseases-National Science and Technology Major Project, Shenqi Medical.
Abstract (original language)
Background
For long coronary lesions, drug‐coated balloons (DCBs) might be an attractive alternative compared with drug‐eluting stents (DES); however, supporting evidence remains scarce.
Aims
To compare the efficacy of DCBs versus DES for treating long de novo coronary lesions.
Methods
REC‐CAGEFREE I was a non‐inferiority trial conducted at 43 sites in China, which randomized 2272 patients to paclitaxel‐coated balloon angioplasty with the option of rescue stenting or sirolimus‐eluting stents for treating de novo lesions, regardless of vessel diameter. In this pre‐specified subgroup analysis, patients were stratified by quantitative coronary angiography‐assessed lesion length into short (< 20 mm) and long (≥ 20 mm) groups. The primary endpoint was a device‐oriented composite endpoint (DoCE, including cardiovascular death, target vessel myocardial infarction, or clinically and physiologically‐indicated target lesion revascularization) at 3 years.
Results
2,223 (97.8%) participants with available angiograms were included, of which 302 (13.6%) had long lesions and 1921 (86.4%) had short lesions. At 3 years, DoCE occurred in 24/302 (8.0%) and 121/1921 (6.3%) patients in long and short groups, respectively. In the long lesions group, DoCE occurred in 14/121 (11.6%) and 10/181 (5.6%) in the DCBs and DES groups, respectively (HR IPTW : 2.46, 95% CI: 1.07–5.67, p = 0.034). In the short lesions group, DoCE occurred in 75/983 (7.7%) and 46/938 (4.9%) in the DCBs and DES groups, respectively (HR IPTW : 1.52, 95% CI: 1.03–2.22, p = 0.033). No significant interaction was observed between lesion length and DES/DCBs (P interaction = 0.460).
Conclusion
DCBs were associated with a higher risk of DoCE compared to DES for treating de novo lesions, regardless of lesion length.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Cardiology, Xijing Hospital, The Fourth Military Medical University, Xi'an, China.
- Department of Cardiology, The First Hospital of Kunming, Kunming, China.
- Department of Cardiology, West China Hospital, Sichuan University, Chengdu, China.
- Department of Cardiology, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
- Department of Cardiology, The Second Xiangya Hospital of Central South University, Changsha, China.
- Department of Cardiology, Tianjin Fourth Central Hospital, Tianjin, China.
ORCID profiles: Xiongwei Bai, Yanqing Wu, Xingqiang He, Patrick W Serruys, Chao Gao
Funding
- Xijing Hospital
- Noncommunicable Chronic Diseases-National Science and Technology Major Project
- Shenqi Medical
- Medisets
Cite
APA
Lv, Y., Yang, F., Bai, X., Wang, H., Wu, Y., Fang, Z., Zhou, J., Gao, H., Hu, T., Sun, D., Wang, Q., Yin, Z., Wen, S., Jin, Y., Hong, L., Liu, J., Fu, G., Zhang, R., He, X., …, & Gao, C. (2026). Drug‐Coated Balloons Versus Drug‐Eluting Stents for Patients With Long De Novo Coronary Artery Lesions: Insights From the REC‐CAGEFREE I Trial. Catheterization and Cardiovascular Interventions, 108(2), 473-482. https://doi.org/10.1002/ccd.70679
Vancouver
Lv Y, Yang F, Bai X, Wang H, Wu Y, Fang Z, et al. Drug‐Coated Balloons Versus Drug‐Eluting Stents for Patients With Long De Novo Coronary Artery Lesions: Insights From the REC‐CAGEFREE I Trial. Catheterization and Cardiovascular Interventions. 2026;108(2):473-482. doi:10.1002/ccd.70679
BibTeX
@article{Lv2026,
author = {Lv, Yuehao and Yang, Feng and Bai, Xiongwei and Wang, Hua and Wu, Yanqing and Fang, Zhenfei and Zhou, Jingyu and Gao, Haokao and Hu, Tao and Sun, Dongdong and Wang, Qiong and Yin, Zhiyong and Wen, Shangyu and Jin, Yuanzhe and Hong, Lang and Liu, Jianzheng and Fu, Guotao and Zhang, Ruining and He, Xingqiang and Zhu, Bin and Jiang, Zhiwei and Xia, Jielai and Capodanno, Davide and Garg, Scot and Onuma, Yoshinobu and Wang, Duolao and Serruys, Patrick W and Tao, Ling and Gao, Chao},
title = {Drug‐Coated Balloons Versus Drug‐Eluting Stents for Patients With Long De Novo Coronary Artery Lesions: Insights From the REC‐CAGEFREE I Trial},
journal = {Catheterization and Cardiovascular Interventions},
year = {2026},
volume = {108},
number = {2},
pages = {473--482},
doi = {10.1002/ccd.70679}
}
EUVIMED